ProShare Advisors’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $938K | Sell |
|
|||||
|
2025
Q1 | $819K | Sell |
|
|||||
|
2024
Q4 | $1.29M | Buy |
|
|||||
|
2024
Q3 | $942K | Buy |
|
|||||
|
2024
Q2 | $754K | Sell |
|
|||||
|
2024
Q1 | $981K | Buy |
|
|||||
|
2023
Q4 | $938K | Buy |
|
|||||
|
2023
Q3 | $829K | Sell |
|
|||||
|
2023
Q2 | $806K | Buy |
|
|||||
|
2023
Q1 | $737K | Sell |
|
|||||
|
2022
Q4 | $819K | Buy |
|
|||||
|
2022
Q3 | $681K | Sell |
|
|||||
|
2022
Q2 | $610K | Sell |
|
|||||
|
2022
Q1 | $920K | Sell |
|
|||||
|
2021
Q4 | $897K | Buy |
|
|||||
|
2021
Q3 | $790K | Sell |
|
|||||
|
2021
Q2 | $1.25M | Buy |
|
|||||
|
2021
Q1 | $540K | Sell |
|
|||||
|
2020
Q4 | $581K | Buy |
|
|||||
|
2020
Q3 | $375K | Buy |
|
|||||
|
2020
Q2 | $371K | Sell |
|
|||||
|
2020
Q1 | $571K | Sell |
|
|||||
|
2019
Q4 | $1.43M | Buy |
|
|||||
|
2019
Q3 | $1.37M | Buy |
|
|||||
|
2019
Q2 | $1.29M | Sell |
|
|||||
|
2019
Q1 | $1.03M | Buy |
|
|||||
|
2018
Q4 | $1.04M | Sell |
|
|||||
|
2018
Q3 | $1.43M | Sell |
|
|||||
|
2018
Q2 | $1.15M | Buy |
|
|||||
|
2018
Q1 | $725K | Sell |
|
|||||
|
2017
Q4 | $635K | Buy |
|
|||||
|
2017
Q3 | $264K | Sell |
|
|||||
|
2017
Q2 | $257K | Sell |
|
|||||
|
2017
Q1 | $333K | Sell |
|
|||||
|
2016
Q4 | $406K | Buy |
|
|||||
|
2016
Q3 | $247K | Sell |
|
|||||
|
2016
Q2 | $264K | Buy |
|
|||||
|
2016
Q1 | $301K | Sell |
|
|||||
|
2015
Q4 | $344K | Buy |
|
|||||
|
2015
Q3 | $250K | Sell |
|
|||||
|
2015
Q2 | $425K | Sell |
|
|||||
|
2015
Q1 | $634K | Sell |
|
|||||
|
2014
Q4 | $558K | Sell |
|
|||||
|
2014
Q3 | $818K | Sell |
|
|||||
|
2014
Q2 | $1.03M | Sell |
|
|||||
|
2014
Q1 | $1.78M | Buy |
|
|||||
|
2013
Q4 | $253K | Sell |
|
|||||
|
2013
Q3 | $1.39M | Sell |
|
|||||
|
2013
Q2 | $1.5M | Buy |
|